
Rishad Sayedmuhammed Kalappurakkal
About Rishad Sayedmuhammed Kalappurakkal
Data last updated:
Rishad Sayedmuhammed Kalappurakkal is a Director at Zygene Biotechnologies Private Limited (since 2019), Director at Klonos Life Sciences Private Limited (since 2017) and Director at Biomend Lifesciences Private Limited (since 2025). The companies operate in Life Sciences, Research & Development and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹7.7 Lakh; the largest is Zygene Biotechnologies Private Limited at ₹7.3 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Jun 2019 | 2019 | ₹7.3 Lakh (FY 2024) | Active | |
| Director | 14 Sep 2017 | 2017 | ₹33,733 (FY 2022) | Active | |
| Director | 07 May 2025 | 2025 | Active |
Board colleagues of Rishad Sayedmuhammed Kalappurakkal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nasiya Kalappurakal Aliyar | 08491912 | Zygene Biotechnologies Private Limited | Director |
| Bineesh Skaria | 07920396 | Klonos Life Sciences Private Limited | Director |
| Firoz A | 11096463 | Biomend Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rishad Sayedmuhammed Kalappurakkal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rishad Sayedmuhammed Kalappurakkal
Rishad Sayedmuhammed Kalappurakkal currently holds 3 directorships: Zygene Biotechnologies Private Limited (Director, since 24 Jun 2019, revenue ₹7.3 Lakh (FY 2024)); Klonos Life Sciences Private Limited (Director, since 14 Sep 2017, revenue ₹33,733 (FY 2022)); Biomend Lifesciences Private Limited (Director, since 07 May 2025).
Rishad Sayedmuhammed Kalappurakkal was first appointed on 14 Sep 2017 as Director at Klonos Life Sciences Private Limited. The most recent appointment on record is 07 May 2025 at Biomend Lifesciences Private Limited.
The 2 current companies of Rishad Sayedmuhammed Kalappurakkal that report revenue have a combined latest revenue of ₹7.7 Lakh: Zygene Biotechnologies Private Limited ₹7.3 Lakh (FY 2024); Klonos Life Sciences Private Limited ₹33,733 (FY 2022).
The current boards of Rishad Sayedmuhammed Kalappurakkal's companies include Nasiya Kalappurakal Aliyar (Zygene Biotechnologies Private Limited), Bineesh Skaria (Klonos Life Sciences Private Limited), Firoz A (Biomend Lifesciences Private Limited).